Table 3 Pathways involved in the RNA-Seq of human Sertoli cells from OA and SCOS testes
Term | Genes (%) | P value | Fold enrichment | FDR | Fisher exact |
|---|---|---|---|---|---|
TGF-beta signaling pathway | 9 (3.1) | 4.1E−4 | 4.9 | 4.7E−1 | 7.5E−5 |
Hedgehog signaling pathway | 5 (1.7) | 2.9E−2 | 2.9 | 2.8E1 | 6.1E−3 |
Pathways in cancer | 13 (4.5) | 3.9E−2 | 4.5 | 3.7E1 | 1.9E−2 |
Bladder cancer | 4 (3.2) | 5.6E−2 | 1.4 | 4.8E1 | 1.1E−2 |
Oocyte meiosis | 5 (2.1) | 7.9E−2 | 2.6 | 6.1E1 | 2.8E−2 |
ECM-receptor interaction | 6 (1.7) | 9.7E−2 | 2.8 | 6.9E1 | 3.1E−2 |